|
|
Office Locations:
|
150 Monument Rd Suite 207
Bala Cynwyd, PA 19004
Phone: 215-988-6800
Fax: 215-988-6801
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 2002, Quaker BioVentures is a venture capital firm dedicated to investing in life science companies located in the Mid-Atlantic region. The firm leads investments in companies across the spectrum of the life science industry, particularly in developing human therapeutic products as well as companies pursuing platform technologies for the biopharmaceutical industry. Quaker also invests in medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at varying stages of development, from early stage businesses to public companies. Quaker manages approximately $700 million in capital, typically investing between $5 million and $25 million in each company, with initial investments ranging from $2.5 million to $12 million. The firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
